Volume 5, Issue 3 (Autumn 2014)                   JAP 2014, 5(3): 29-35 | Back to browse issues page

XML Persian Abstract Print


1- , manesthesist@yahoo.com
Abstract:   (7028 Views)

Aims and background:  Nowadays, multimodal approach is used to control post-operative pain. Pregabalin has been shown to have analgesic effects on postoperative pain as a Gaba-Amino-Buteric (GABA) analogue. This prospective, randomized, double-blind, controlled study has evaluated the beneficial effect of Pregabalin pretreatment on postoperative pain and opioid consumption in patints undergoing orthopedic elective surgery.

Materials and Methods: Sixty ASA 1-2 patients, scheduled for orthopedic elective surgery under spinal anesthesia, were randomly divided into two groups. Group 1 received 300 mg Pregabalin one hour before the operation and Group 2 was given Placebo capsule. Patient-controlled intravenous analgesia (PCIA) device, prepared with Sufentanil, was connected to both groups for postoperative analgesia. Postoperative pain scores according to visual analogue scale (VAS), opioid consumption, and side-effects like nausea were recorded for 12 hours after surgery. P value<0.05 was considered significant.

Findings: According to visual analogue scale (VAS), pain scores were significantly lower in Pregabalin group at post anesthesia care unit (PACU), 6 hours and 12 hours post-operatively(p<0.05). Also pethidine consumption was significantly less than the placebo group in Pregabalin group (p<0.05).

Conclusion: Administering a single dose of 300 mg Pregabalin orally, and 1 hour before elective orthopedic  surgery under spinal anesthesia, significantly reduces postoperative pain and opioid consumption.

Full-Text [PDF 303 kb]   |   Full Text (HTML)   (2240 Downloads)    
Type of Study: Original | Subject: Acute pain managment
Received: 2014.09.7 | Accepted: 2014.09.7 | Published: 2014.09.7

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.